TRI-JORDYNA 21

Identification of Tri-Jordyna 21

No description

Google image searchProduct monograph

Active ingredients

ethinyl estradiol, 0.035 MG

norgestimate, 0.18 MG

norgestimate, 0.215 MG

ethinyl estradiol, 0.035 MG

norgestimate, 0.25 MG

ethinyl estradiol, 0.035 MG

DIN: 02486296

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: GLENMARK PHARMACEUTICALS CANADA INC.

Date: 08-JUL-2020

ATC:

• G03 — SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (ATC, ATC/DDD, )
• G03A — HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE (ATC, ATC/DDD)
• G03AB — Progestogens and estrogens, sequential preparations (ATC, ATC/DDD)
• G03AB09 — NORGESTIMATE AND ETHINYLESTRADIOL (ATC/DDD)

Reference brand drug: Tri-cira

Pharmaceutical standard: USP

External Links for Tri-Jordyna 21

Search on Google

• Tri-Jordyna 21 side effects
• Tri-Jordyna 21 dosage
• ethinyl estradiol side effects
• ethinyl estradiol dosage
• norgestimate side effects
• norgestimate dosage
• norgestimate side effects
• norgestimate dosage
• ethinyl estradiol side effects
• ethinyl estradiol dosage
• norgestimate side effects
• norgestimate dosage
• ethinyl estradiol side effects
• ethinyl estradiol dosage